Epilepsy Research
Volume 79, Issue 1 , Pages 78-83, March 2008

Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring

  • Nabil J. Azar

      Affiliations

    • Department of Neurology, Vanderbilt University Medical Center, A-0118 MCN 2551, Nashville, TN 37232-2551, United States
  • ,
  • Lily Wang

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, A-0118 MCN 2551, Nashville, TN 37232-2551, United States
  • ,
  • Yanna Song

      Affiliations

    • Department of Biostatistics, Vanderbilt University Medical Center, A-0118 MCN 2551, Nashville, TN 37232-2551, United States
  • ,
  • Bassel W. Abou-Khalil

      Affiliations

    • Department of Neurology, Vanderbilt University Medical Center, A-0118 MCN 2551, Nashville, TN 37232-2551, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 615 936 2591; fax: +1 615 936 0223.

Received 24 October 2007; received in revised form 6 December 2007; accepted 29 December 2007.

Summary 

Purpose

To compare the temporal pattern of seizures after acute withdrawal of oxcarbazepine (OXC) and phenytoin (PHT) in the epilepsy monitoring unit (EMU).

Methods

We identified all epilepsy patients admitted to our EMU on OXC or PHT monotherapy, over a period of 5 years. The OXC taper usually occurred over 2 days while PHT was abruptly discontinued on admission day. For each patient, we recorded the number and type of seizures for each EMU day. We used Poisson regression models to estimate daily seizure frequency separately for complex partial seizures (CPSs) and generalized tonic–clonic seizures (GTCSs).

Results

Forty patients were admitted on OXC and 32 on PHT monotherapy. The temporal distribution of seizures varied between the two groups. The first GTCS was more likely to occur in the first 2 days of monitoring for the OXC group (p<0.046). There was a higher frequency of GTCS on day 2 of admission in the OXC group (p=0.011). The groups did not differ in the pattern of CPS.

Conclusions

OXC is disproportionately associated with increased GTCS in the first 2 days after acute withdrawal. The early peak of GTCS favors a rebound phenomenon in addition to loss of therapeutic effect.

Keywords: Withdrawal seizures, Epilepsy monitoring, Rebound phenomenon, Oxcarbazepine, Phenytoin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-1211(08)00010-7

doi:10.1016/j.eplepsyres.2007.12.014

Epilepsy Research
Volume 79, Issue 1 , Pages 78-83, March 2008